NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iris Energy Limited (“Iris” or the “Company”) (NASDAQ: IREN). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CenterPoint Energy, Inc. (“CenterPoint” or the “Company”) (NYSE: CNP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The […]